15700626

Source:http://linkedlifedata.com/resource/pubmed/id/15700626

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034927, umls-concept:C0035201, umls-concept:C0205210, umls-concept:C0231491, umls-concept:C0450442, umls-concept:C0521116, umls-concept:C0971473, umls-concept:C1527148, umls-concept:C2003941
pubmed:issue	14
pubmed:dateCreated	2005-2-9
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8712059
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cilengitide, http://linkedlifedata.com/resource/pubmed/chemical/Integrin alphaV, http://linkedlifedata.com/resource/pubmed/chemical/Snake Venoms
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0890-9091
pubmed:author	pubmed-author:ColevasA DimitriosAD, pubmed-author:MasonSchoenfeldtS, pubmed-author:ScharfOritO
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1778, 1781-2, 1784
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15700626-Animals, pubmed-meshheading:15700626-Antineoplastic Agents, pubmed-meshheading:15700626-Clinical Trials as Topic, pubmed-meshheading:15700626-Humans, pubmed-meshheading:15700626-Integrin alphaV, pubmed-meshheading:15700626-Neoplasms, pubmed-meshheading:15700626-Snake Venoms
pubmed:year	2004
pubmed:articleTitle	Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.
pubmed:affiliation	National Cancer Institute, Investigational Drug Branch, Cancer Therapy Evaluation Program, Bethesda, MD, USA.
pubmed:publicationType	Directory